Physician profile
Robert L Levine
NPI 1992824296
$33,375.85
in general payments reported to CMS, 2019-2025
12 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,580 · 2020: $4,712 · 2021: $4,338 · 2022: $4,042 · 2023: $3,527 · 2024: $8,870 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Travel and Lodging: $856 · Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,073.50 |
| Travel and Lodging | $856.42 |
| Food and Beverage | $772.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $22,969.96 | 2019-2025 | Sogroya, Wegovy |
| Ascendis Pharma Endocrinology INC | $5,841.61 | 2022-2024 | |
| Dexcom, INC. | $3,257.96 | 2019 | |
| Insulet Corporation | $333.43 | 2019-2025 | Omnipod |
| Vyne Pharmaceuticals INC. | $306.92 | 2020-2021 | |
| Tandem Diabetes Care, INC. | $246.93 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $134.79 | 2025 | Strensiq |
| Medtronic Minimed, INC. | $125.32 | 2019 | |
| Beta Bionics, INC. | $108.08 | 2024 | Ilet Bionic Pancreas |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.94 | 2020 | |
| Abbvie INC. | $17.87 | 2023 | |
| Biodelivery Sciences International, INC. | $13.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.